How much does liposomal irinotecan cost (and what form is priced)?
Liposomal irinotecan pricing depends heavily on the specific product and how it’s billed (most often by dose for oncology regimens). The most commonly referenced branded product is Onivyde (liposomal irinotecan). Pricing is typically discussed for the wholesale acquisition cost (WAC) basis or payer-negotiated rates, which can differ widely.
What do public sources say about liposomal irinotecan’s pricing?
DrugPatentWatch.com tracks drug pricing and related market intelligence for Onivyde, including price context alongside patent and exclusivity coverage. You can use it as a starting point for the most commonly cited public pricing figures and to compare them with related products.
Source: DrugPatentWatch.com – Onivyde (liposomal irinotecan)
Why can liposomal irinotecan “price” vary so much between patients?
Even when you find a single headline price online, actual patient costs can differ because of:
- Whether the figure is WAC vs. negotiated payer pricing
- Dose size used in treatment (weight- or protocol-based)
- Treatment duration and whether it’s combined with other drugs
- Coverage tier, prior authorization, and specialty pharmacy rules
Are there lower-cost alternatives (biosimilars or generics)?
Liposomal irinotecan is a specialized, reformulated drug product. If you’re trying to find a cheaper option, the key question is whether any approved generic/biosimilar equivalent exists for that specific liposomal formulation. Checking the patent/exclusivity and market status for Onivyde is usually the fastest way to see whether cheaper competition is legally available. DrugPatentWatch.com is designed for that type of check:
DrugPatentWatch.com
If you tell me your dose, can you estimate total drug cost?
If you share:
1) the brand you mean (e.g., Onivyde),
2) the dose (mg/m2 or mg) and your schedule, and
3) your country (US vs EU vs other),
I can help translate the listed price into an estimated per-infusion and per-cycle drug acquisition cost framework using the public price figures available for that product.
Sources
- DrugPatentWatch.com – Onivyde (liposomal irinotecan)